{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:41:03Z","timestamp":1793922063924,"version":"4.8.0"},"reference-count":52,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The hallmark of heparin-induced thrombocytopenia (HIT) is the presence of immunoglobulin G (IgG) antibodies against platelet factor 4\/heparin (PF4\/H) complexes, typically detected by PF4\/H enzyme-linked immunosorbent assay (ELISA); thus, negative ELISA results are commonly used to exclude this diagnosis. Here, we report a prevalent yet previously unrecognized subset of antibodies that are undetectable by PF4\/H ELISA (ELISA\u2212) but activate platelets in the PF4-dependent P-selectin expression assay (PEA+). In 11 patients with clinically confirmed HIT who tested positive in both PF4\/H ELISA and platelet activation assays, ELISA\u2212PEA+ antibodies accounted for 65% \u00b1 19% of total platelet-activating IgG activity and coexisted with ELISA+PEA+ antibodies. Consistent with this finding, single-cell cloning from 7 patients with HIT identified 23 PEA+ antibody-producing B-cell clones, of which 17 were ELISA\u2212, outnumbering the ELISA+ clones. Functionally, ELISA\u2212PEA+ antibodies closely resembled ELISA+PEA+ antibodies: platelet binding and activation required exogenous PF4 and were inhibited by Fc\u03b3RIIA blockade, high-dose heparin, or Fab fragments made from ELISA+PEA+ antibodies. Importantly, these antibodies induced thrombocytopenia in a humanized mouse model of HIT. Despite lacking PF4\/H reactivity in ELISAs, they recognize PF4 on platelets and showed no appreciable binding to neutrophil-activating peptide-2, interleukin-8, or PF4 alone. Structurally, these antibodies were heterogeneous, with a subset sharing heavy-chain features with ELISA+PEA+ antibodies. Collectively, our findings demonstrate that ELISA\u2212PEA+ antibodies are a common, previously unrecognized feature of HIT, with functional relevance, supporting the possibility that they play an important, perhaps even central, role in HIT pathogenesis. Defining their prevalence, kinetics, and clinical impact deserves high priority for further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025032317","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T17:06:31Z","timestamp":1776791191000},"page":"115-129","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["Non-PF4\/heparin-binding, platelet-activating antibodies in heparin-induced thrombocytopenia"],"prefix":"10.1182","volume":"148","author":[{"given":"Lu","family":"Zhou","sequence":"first","affiliation":[{"name":"1Versiti Blood Research Institute, Milwaukee, WI"},{"name":"2Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2045-5152","authenticated-orcid":false,"given":"Andrew","family":"Cao","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Milwaukee, WI"},{"name":"2Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhu","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Milwaukee, WI"},{"name":"2Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Villalobos-Garcia","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisela","family":"Marchan","sequence":"additional","affiliation":[{"name":"3Diagnostic Laboratories, Versiti Blood Center of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-9081","authenticated-orcid":false,"given":"Brian","family":"Curtis","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Milwaukee, WI"},{"name":"3Diagnostic Laboratories, Versiti Blood Center of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1990-3077","authenticated-orcid":false,"given":"Lubica","family":"Rauova","sequence":"additional","affiliation":[{"name":"4Hematology Division, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"5Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mortimer","family":"Poncz","sequence":"additional","affiliation":[{"name":"4Hematology Division, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"5Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Aster","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-4377","authenticated-orcid":false,"given":"Anand","family":"Padmanabhan","sequence":"additional","affiliation":[{"name":"6Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5549-3795","authenticated-orcid":false,"given":"Demin","family":"Wang","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Milwaukee, WI"},{"name":"2Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2420-8212","authenticated-orcid":false,"given":"Renren","family":"Wen","sequence":"additional","affiliation":[{"name":"1Versiti Blood Research Institute, Milwaukee, WI"},{"name":"2Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"21","key":"2026070211221728700_bib1","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"key":"2026070211221728700_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.med.50.1.129","article-title":"Heparin-induced thrombocytopenia: a ten-year retrospective","volume":"50","author":"Warkentin","year":"1999","journal-title":"Annu Rev Med"},{"issue":"6","key":"2026070211221728700_bib3","first-page":"576","article-title":"Heparin-induced thrombocytopenia","volume":"21","author":"Warkentin","year":"2015","journal-title":"Curr Opin Crit Care"},{"issue":"5","key":"2026070211221728700_bib4","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1016\/S2352-3026(18)30046-2","article-title":"Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study","volume":"5","author":"Dhakal","year":"2018","journal-title":"Lancet Haematol"},{"issue":"3","key":"2026070211221728700_bib5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1096-8652(199703)54:3<196::AID-AJH4>3.0.CO;2-R","article-title":"Characterization of the humoral immune response in heparin-induced thrombocytopenia","volume":"54","author":"Suh","year":"1997","journal-title":"Am J Hematol"},{"issue":"3","key":"2026070211221728700_bib6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0022-2143(97)90022-6","article-title":"Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa \"low responder\" (his131) gene in patients with heparin-induced thrombocytopenia","volume":"130","author":"Denomme","year":"1997","journal-title":"J Lab Clin Med"},{"issue":"2","key":"2026070211221728700_bib7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.V89.2.370","article-title":"Fc gamma RIIA H\/R 131 polymorphism, subclass-specific IgG anti-heparin\/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis","volume":"89","author":"Arepally","year":"1997","journal-title":"Blood"},{"issue":"14","key":"2026070211221728700_bib8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJM198010023031404","article-title":"Heparin-associated thrombocytopenia","volume":"303","author":"Cines","year":"1980","journal-title":"N Engl J Med"},{"issue":"1","key":"2026070211221728700_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1614206","article-title":"Heparin-induced thrombocytopenia: towards consensus","volume":"79","author":"Warkentin","year":"1998","journal-title":"Thromb Haemost"},{"issue":"6","key":"2026070211221728700_bib10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/ajcp\/104.6.648","article-title":"Comparison of PF4\/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia","volume":"104","author":"Arepally","year":"1995","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2026070211221728700_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0038-1651670","article-title":"Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases","volume":"73","author":"Amiral","year":"1995","journal-title":"Thromb Haemost"},{"issue":"suppl 1","key":"2026070211221728700_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1538-7836.2009.03385.x","article-title":"Heparin-induced thrombocytopenia","volume":"7","author":"Greinacher","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2026070211221728700_bib13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ajh.21032","article-title":"What is the potential for overdiagnosis of heparin-induced thrombocytopenia?","volume":"82","author":"Lo","year":"2007","journal-title":"Am J Hematol"},{"issue":"20","key":"2026070211221728700_bib14","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"2026070211221728700_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/asheducation-2011.1.143","article-title":"How I diagnose and manage HIT","volume":"2011","author":"Warkentin","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"2026070211221728700_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1160\/TH11-09-0631","article-title":"Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: results of a large Australian study","volume":"107","author":"Morel-Kopp","year":"2012","journal-title":"Thromb Haemost"},{"issue":"1","key":"2026070211221728700_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","article-title":"A diagnostic test for heparin-induced thrombocytopenia","volume":"67","author":"Sheridan","year":"1986","journal-title":"Blood"},{"issue":"22","key":"2026070211221728700_bib18","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"issue":"3","key":"2026070211221728700_bib19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.chest.2016.02.641","article-title":"A novel PF4-dependent platelet activation assay identifies patients likely to have heparin-induced thrombocytopenia\/thrombosis","volume":"150","author":"Padmanabhan","year":"2016","journal-title":"Chest"},{"issue":"8","key":"2026070211221728700_bib20","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.2020008195","article-title":"A prospective, blinded study of a PF4-dependent assay for HIT diagnosis","volume":"137","author":"Samuelson Bannow","year":"2021","journal-title":"Blood"},{"issue":"9","key":"2026070211221728700_bib21","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood.2022017612","article-title":"Cloned antibodies from patients with HIT provide new clues to HIT pathogenesis","volume":"141","author":"Zhu","year":"2023","journal-title":"Blood"},{"issue":"6","key":"2026070211221728700_bib22","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood-2005-08-3122","article-title":"Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications","volume":"107","author":"Rauova","year":"2006","journal-title":"Blood"},{"issue":"8","key":"2026070211221728700_bib23","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","article-title":"Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA","volume":"98","author":"Reilly","year":"2001","journal-title":"Blood"},{"issue":"10","key":"2026070211221728700_bib24","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/jth.13786","article-title":"5B9, a monoclonal antiplatelet factor 4\/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies","volume":"15","author":"Kizlik-Masson","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2026070211221728700_bib25","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood.V95.5.1533.005k01_1533_1540","article-title":"Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies","volume":"95","author":"Arepally","year":"2000","journal-title":"Blood"},{"issue":"1","key":"2026070211221728700_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1182\/blood-2014-06-580894","article-title":"Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis","volume":"125","author":"Padmanabhan","year":"2015","journal-title":"Blood"},{"issue":"6","key":"2026070211221728700_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2017-08-803031","article-title":"Normal plasma IgG inhibits HIT antibody-mediated platelet activation: implications for therapeutic plasma exchange","volume":"131","author":"Jones","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2026070211221728700_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V88.2.410.bloodjournal882410","article-title":"Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia","volume":"88","author":"Amiral","year":"1996","journal-title":"Blood"},{"issue":"4","key":"2026070211221728700_bib29","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood-2002-02-0620","article-title":"Platelet activation induced by human antibodies to interleukin-8","volume":"101","author":"Regnault","year":"2003","journal-title":"Blood"},{"issue":"7873","key":"2026070211221728700_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"issue":"20","key":"2026070211221728700_bib31","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMc2409428","article-title":"Diagnostic complexity in monoclonal gammopathy of thrombotic significance","volume":"391","author":"Kanack","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"2026070211221728700_bib32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood.2024025010","article-title":"Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19","volume":"145","author":"Zhu","year":"2025","journal-title":"Blood"},{"issue":"7","key":"2026070211221728700_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ajh.24025","article-title":"Pitfalls in the diagnosis of heparin-Induced thrombocytopenia: a 6-year experience from a reference laboratory","volume":"90","author":"Nazi","year":"2015","journal-title":"Am J Hematol"},{"issue":"3","key":"2026070211221728700_bib34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ajh.26075","article-title":"Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?","volume":"96","author":"Warkentin","year":"2021","journal-title":"Am J Hematol"},{"issue":"2","key":"2026070211221728700_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/hematolrep16020029","article-title":"Anti-PF4 ELISA-negative, SRA-positive heparin-induced thrombocytopenia","volume":"16","author":"Attah","year":"2024","journal-title":"Hematol Rep"},{"key":"2026070211221728700_bib36","doi-asserted-by":"publisher","DOI":"10.1101\/2025.10.29.25338884","article-title":"Pathogenic PF4\/polyvinylsulfonate ELISA-negative antibodies in HIT","author":"Kanack","year":"6  2025","journal-title":"medRxiv"},{"key":"2026070211221728700_bib37","author":"Allyson","year":"2018"},{"issue":"1","key":"2026070211221728700_bib38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1182\/blood.V96.1.182","article-title":"Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation","volume":"96","author":"Newman","year":"2000","journal-title":"Blood"},{"issue":"1","key":"2026070211221728700_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1172\/JCI116987","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells","volume":"93","author":"Visentin","year":"1994","journal-title":"J Clin Invest"},{"issue":"1","key":"2026070211221728700_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-2007-1000384","article-title":"Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis","volume":"21","author":"Greinacher","year":"1995","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"2026070211221728700_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jcp.50.1.5","article-title":"Laboratory investigation of immune thrombocytopenia","volume":"50","author":"Warner","year":"1997","journal-title":"J Clin Pathol"},{"issue":"1","key":"2026070211221728700_bib42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1067\/mlc.2001.115525","article-title":"Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia\/thrombosis","volume":"138","author":"Visentin","year":"2001","journal-title":"J Lab Clin Med"},{"issue":"16","key":"2026070211221728700_bib43","doi-asserted-by":"crossref","first-page":"10518","DOI":"10.1016\/S0021-9258(18)99255-0","article-title":"Characterization of a heparan sulfate and a peculiar chondroitin 4-sulfate proteoglycan from platelets. Inhibition of the aggregation process by platelet chondroitin sulfate proteoglycan","volume":"266","author":"Nader","year":"1991","journal-title":"J Biol Chem"},{"issue":"14","key":"2026070211221728700_bib44","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/S0021-9258(17)33292-1","article-title":"Purification and binding properties of human platelet factor four","volume":"251","author":"Handin","year":"1976","journal-title":"J Biol Chem"},{"issue":"1","key":"2026070211221728700_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0049-3848(87)90209-X","article-title":"Interrelationship of protamine and platelet factor 4 in the neutralization of heparin","volume":"46","author":"Shanberge","year":"1987","journal-title":"Thromb Res"},{"issue":"suppl 1","key":"2026070211221728700_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood-2020-138781","article-title":"Polyreactivity and somatic hypermutation analysis reveals the innate B cell origin of human PF4\/heparin reactive antibodies [abstract]","volume":"136","author":"Zhu","year":"2020","journal-title":"Blood"},{"issue":"6385","key":"2026070211221728700_bib47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.aao3859","article-title":"Germinal center antibody mutation trajectories are determined by rapid self\/foreign discrimination","volume":"360","author":"Burnett","year":"2018","journal-title":"Science"},{"issue":"1","key":"2026070211221728700_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imr.12808","article-title":"Clonal redemption and clonal anergy as mechanisms to balance B cell tolerance and immunity","volume":"292","author":"Burnett","year":"2019","journal-title":"Immunol Rev"},{"issue":"25","key":"2026070211221728700_bib49","doi-asserted-by":"crossref","first-page":"E2567","DOI":"10.1073\/pnas.1406974111","article-title":"Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity","volume":"111","author":"Sabouri","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070211221728700_bib50","doi-asserted-by":"crossref","first-page":"951385","DOI":"10.3389\/fimmu.2022.951385","article-title":"B cells in the balance: offsetting self-reactivity avoidance with protection against foreign","volume":"13","author":"Young","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"2026070211221728700_bib51","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa2514824","article-title":"Adenoviral inciting antigen and somatic hypermutation in VITT","volume":"394","author":"Wang","year":"2026","journal-title":"N Engl J Med"},{"issue":"16","key":"2026070211221728700_bib52","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1182\/bloodadvances.2024015076","article-title":"Platelet-activating histone\/antihistone IgG complexes in anti-PF4-negative thrombosis and thrombocytopenia syndrome","volume":"9","author":"Esefeld","year":"2025","journal-title":"Blood Adv"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/1\/115\/2531379\/blood_bld-2025-032317-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/1\/115\/2531379\/blood_bld-2025-032317-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:30:43Z","timestamp":1783006243000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/1\/115\/567887\/Non-PF4-heparin-binding-platelet-activating"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025032317","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,2]]},"published":{"date-parts":[[2026,7,2]]}}}